The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin‐8 production

Michihisa Moriguchi(Kyoto Prefectural University of Medicine), Keizo Kagawa(Fukuyama City Hospital), Hidetaka Takashima(Kyoto Prefectural University of Medicine), Takeshi Okanoue(University Hospitals Birmingham NHS Foundation Trust), Tatsuo Katagishi(Kyoto Prefectural University of Medicine), Tadashi Watanabe(Aichi Medical University), Hiroyuki Kimura(Kyoto Prefectural University of Medicine), Tomoki Nakajima(Kyoto Prefectural University of Medicine), Yasuhide Mitsumoto(Saiseikai Suita Hospital)
International Journal of Cancer
October 11, 2002
Cited by 96


Related Papers